The Dallas-based specialty care platform, valued at $1 billion in 2023 and now rebranded as Lantern, has expanded its ...

Teladoc’s (TDOC) recent second-quarter financial ... After posting Q2 results, the new management team withdrew the ...

Absent of any other stock-moving news, a 25% increase in an analyst's price target for Teladoc (NYSE: TDOC) got the stock ...

Teladoc Health is one of the stocks that had a crazy run during COVID and then fell hard. See what makes TDOC a potential ...

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $10.57, a high estimate of ...

Teladoc health is prime for more upside after new management seems to be bringing in positive results for the company.

Teladoc Health’s TDOC shares rose nearly 12 ... was cited as the reason for the price target increase. Jefferies analyst team highlighted a 12% increase in BetterHelp's web traffic in July ...

Adam Spatacco has positions in Eli Lilly and Novo Nordisk. The Motley Fool has positions in and recommends Pfizer, Target, and Teladoc Health. The Motley Fool recommends Johnson & Johnson, Moderna, ...

Teladoc Health Inc (TDOC) stock saw a modest uptick, ending the day at $8.09 which represents a slight increase of $0.47 or 6.17% from the prior close of $7.62. The stock opened at $7.77 and touched a ...